Fresenius Medical Care AG (FMS)
NYSE: FMS · Real-Time Price · USD
25.66
-0.04 (-0.16%)
At close: Jul 31, 2026, 4:00 PM EDT
25.67
+0.01 (0.04%)
After-hours: Jul 31, 2026, 7:34 PM EDT

Fresenius Medical Care AG Stock Forecast

Stock Price Forecast

According to 7 analysts polled by S&P Global, Fresenius Medical Care AG stock has a consensus rating of "Hold" and an average price target of $25.6. The average 1-year stock price forecast is 0.23% lower than the current stock price, while the lowest is $18.11 (-29.42%) and the highest is $37.86 (+47.54%).

Price Target: $25.6 (-0.23%)
Analyst Consensus: Hold

Price Target

Chart
TargetLowAverageMedianHigh
Price$18.11$25.6$25.38$37.86
Change-29.42%-0.23%-1.09%+47.54%

Analyst Ratings

The average analyst rating for Fresenius Medical Care AG stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Chart
RatingFeb '26Mar '26Apr '26May '26Jun '26Jul '26
Strong Buy122221
Buy100001
Hold333322
Sell111112
Strong Sell111111
Total777767

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Exane BNP Paribas
Exane BNP Paribas
Sell
Downgrades
$20
SellDowngrades$20-22.45%Jul 28, 2026
Truist Financial
Truist Financial
Hold
Maintains
$26
HoldMaintains$26+1.33%May 21, 2026

Financial Forecast

Revenue This Year
19.49B
from 19.63B
Decreased by -0.70%
Revenue Next Year
20.22B
from 19.49B
Increased by 3.73%
EPS This Year
3.94
from 4.28
Decreased by -7.85%
EPS Next Year
4.40
from 3.94
Increased by 11.62%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
17.62B19.40B19.45B19.34B19.63B19.49B
Revenue Growth
-1.35%10.10%0.29%-0.61%1.51%-0.70%
Gross Profit
4.77B4.89B4.93B4.76B5.03B5.05B
Gross Margin
27.09%25.23%25.32%24.60%25.62%25.90%
Operating Income
1.90B1.54B1.52B1.54B1.87B1.94B
Net Income
969.31M673.41M499.00M537.91M978.37M810.69M
EPS
----4.283.94
EPS Growth
----37.62%-7.85%
Forward PE
-----5.64
Dividend / Share
1.351.121.191.441.491.40
Dividend Growth
--17.04%6.25%21.01%3.47%-6.17%
Free Cash Flow
1.70B1.02B1.31B2.03B1.56B1.59B
No. Analysts
-----17
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.

Revenue Forecast

Revenue202620272028
High20.8B
Avg19.5B
Low19.0B

Revenue Growth

Revenue Growth202620272028
High
5.9%
Avg
-0.7%
Low
-3.1%

EPS Forecast

EPS202620272028
High4.11
Avg3.94
Low3.70

EPS Growth

EPS Growth202620272028
High
-4.0%
Avg
-7.8%
Low
-13.6%